📰 Pharmaceutical Development News
Page 6 - Pharmaceutical Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharmaceutical Development. Real-time updates on events, politics, business and more.
February 26, 2023
The Food and Drug Administration has flagged Guillain-Barre syndrome, a rare neurological condition, as a potential risk for Pfizer’s respiratory syncytial virus vaccine. Two people in their 60s who received
February 23, 2023
A prescription drug that helps Lore Wilkinson walk and talk despite a rare muscle disease cost her so little for more than a decade that she didn’t even use her
February 21, 2023
/PRNewswire/ -- The "Latest Process Validation Guidance Requirements course (FDA and EU Annex 15: Qualifications and Validation)" training has been added to...
February 21, 2023
Following a rigorous application process, we are proud to announce that Seda have been selected as the UK Life Sciences Innovator Winner 2023 in the Application, Product & Service Design Category.
February 15, 2023
NORTHAMPTON, MA / ACCESSWIRE / February 15, 2023 / Innovation is at the core of Gilead's 35-year history of life-changing medicines. Through bold and transformative science, Gilead has developed therapies
January 17, 2023
/PRNewswire/ -- DelveInsights Immune Thrombocytopenia Market Insights report includes a comprehensive understanding of current treatment practices, immune...
January 17, 2023
The overall immune thrombocytopenia market is anticipated to surge owing to the increasing prevalence of the disease along with promising emerging pipeline therapy during the forecasted period
December 13, 2022
DUBLIN--(BUSINESS WIRE)--The "2023 Controlled & Modified Drug Release Summit" conference has been added to ResearchAndMarkets.com's offering.The next generation of drug and therapeutic delivery is here.Attend and connect with 160+ senior drug development innovators this May and uncover the industry's latest formulat...
November 17, 2022
This autumn, BMC Pharmacology and Toxicology flew to Boston, Massachusetts to attend the AAPS PharmSci 360 2022 Meeting. Boasting over 4,100+ attendees, 550 sessions, and just under 900 poster presentations, the 2022 meeting became the intersection for pharmaceutical scientists in industry, academia and government to exchange ideas, foster networks, and keep up with the latest innovative research.
November 10, 2022
Conference Call and Live Audio Webcast Scheduled for Thursday, November 10, 2022, at 10:00 a.m. ET Corporate Highlights Successful leadership transition with...